{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:21:12Z","timestamp":1694640072957},"reference-count":135,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ncl.2010.03.019","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T11:04:51Z","timestamp":1283598291000},"page":"1005-1035","source":"Crossref","is-referenced-by-count":3,"title":["Treatments for Neuro-Ophthalmologic Conditions"],"prefix":"10.1016","volume":"28","author":[{"suffix":"Jr.","given":"Byron Roderick","family":"Spencer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen B.","family":"Digre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/IIO.0b013e3181a8db88","article-title":"Retinal vascular occlusion syndromes","volume":"49","author":"Haymore","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ncl.2010.03.019_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/WNO.0b013e31814b1f66","article-title":"Thrombolysis for central retinal artery occlusion","volume":"27","author":"Biousse","year":"2007","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/ICU.0b013e328329b5d5","article-title":"Thrombolytic therapy in central retinal artery occlusion: cutting edge therapy, standard of care therapy, or impractical therapy","volume":"20","author":"Hazin","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00006982-198707040-00006","article-title":"Recurrent branch retinal artery occlusion associated with CMV infection","volume":"7","author":"Digre","year":"1987","journal-title":"Retina"},{"key":"10.1016\/j.ncl.2010.03.019_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0161-6420(80)35283-4","article-title":"Central retinal artery occlusion and retinal tolerance time","volume":"87","author":"Hayreh","year":"1980","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bjo.2007.133488","article-title":"Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review","volume":"92","author":"Noble","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00417-006-0488-y","article-title":"Response to comment: multicentre study of the European Assessment Group for Lysis in the Eye (EAGLE-Group) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE study report no. 1","volume":"245","author":"Feltgen","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10072-008-0004-8","article-title":"The spectrum of Susac's syndrome","volume":"30","author":"Pawate","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2010.03.019_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jns.2007.01.031","article-title":"Treatment of Susac's syndrome","volume":"257","author":"Rennebohm","year":"2007","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2010.03.019_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11940-008-0008-y","article-title":"Treatment of Susac's syndrome","volume":"10","author":"Rennebohm","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib11","first-page":"133","article-title":"The epidemiology of retinal vein occlusion: the Beaver Dam Eye study","volume":"98","author":"Klein","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ncl.2010.03.019_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2010.03.019_bib13","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1007\/BF02343041","article-title":"Haemorheology in patients with branch retinal vein occlusion with and without risk factors","volume":"234","author":"Remky","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ajo.2003.10.024","article-title":"Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion","volume":"137","author":"Kuhli","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/bjo.85.10.1174","article-title":"Is activated factor VII associated with retinal vein occlusion?","volume":"85","author":"Kadayifcilar","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(99)00074-4","article-title":"Retinal vascular occlusion and deficiencies in the protein C pathway","volume":"128","author":"Greiner","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/sj.eye.6702060","article-title":"Recurrent branch retinal vein occlusion with factor V Leiden mutation","volume":"20","author":"Banik","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.ncl.2010.03.019_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(98)95012-6","article-title":"Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the Eye Disease Case-Control study","volume":"105","author":"Sperduto","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02713680701851902","article-title":"Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities","volume":"33","author":"Rehak","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ncl.2010.03.019_bib20","first-page":"371","article-title":"Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases","volume":"79","author":"Green","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ncl.2010.03.019_bib21","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/S0161-6420(99)90483-9","article-title":"Pathophysiology and hemodynamics of branch retinal vein occlusion","volume":"106","author":"Christoffersen","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9394(79)90193-4","article-title":"The treatment of acute branch vein occlusion by photocoagulation","volume":"87","author":"Wetzig","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib23","first-page":"178","article-title":"The natural course of temporal retinal vein occlusion","volume":"78","author":"Gutman","year":"1974","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.ncl.2010.03.019_bib24","first-page":"166","article-title":"Natural course of temporal retinal branch occlusion","volume":"78","author":"Michels","year":"1974","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"10.1016\/j.ncl.2010.03.019_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9394(14)76979-X","article-title":"The natural course of central retinal vein occlusion","volume":"110","author":"Quinlan","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.019_bib26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about retinal vascular occlusive disorders","volume":"24","author":"Hayreh","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ncl.2010.03.019_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0420.2006.00850.x","article-title":"Intravitreal bevacizumab for branch retinal vein occlusion","volume":"85","author":"Spandau","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ncl.2010.03.019_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00920022","article-title":"Differentiation of ischemic from nonischemic central retinal vein occlusion during the early acute phase","volume":"228","author":"Hayreh","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","article-title":"Baseline and early natural history report. The Central Vein Occlusion Study","volume":"111","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(98)93030-5","article-title":"Terson syndrome, results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage","volume":"105","author":"Kuhn","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib31","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0161-6420(01)00673-X","article-title":"Terson syndrome, a case report suggesting the mechanism of vitreous hemorrhage","volume":"108","author":"Ogawa","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1755-3768.2008.01200.x","article-title":"Outcome indicators for vitrectomy in Terson syndrome","volume":"87","author":"Garweg","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib33","first-page":"106","volume":"37","author":"Roux","year":"1991","journal-title":"Neurochirurgie"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.019_bib34","first-page":"743","article-title":"Terson syndrome: CT evaluation in 12 patients","volume":"19","author":"Swallow","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ncl.2010.03.019_bib35","series-title":"Optic nerve disorders: diagnosis and management (text)","author":"Chan","year":"2007"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3949\/ccjm.76a.07268","article-title":"Optic neuritis and risk of MS: differential diagnosis and management","volume":"76","author":"Osborne","year":"2009","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/01.CON.0000293639.90492.59","article-title":"Diagnosis and differential diagnosis of multiple sclerosis","volume":"13","author":"Rinker","year":"2007","journal-title":"Contiunuum Lifelong Learning Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2010.03.019_bib38","first-page":"789","article-title":"Optic neuritis more than a loss of vision","volume":"30","author":"Chu","year":"2000","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.ncl.2010.03.019_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group","volume":"111","author":"Keltner","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archopht.1992.01080150029020","article-title":"The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group [editorial]","volume":"110","author":"Beck","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib41","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.019_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1590\/S0004-282X2008000100034","article-title":"Devic's neuromyelitis optica","volume":"66","author":"Peixoto","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ncl.2010.03.019_bib43","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib44","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A\u00a0serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2010.03.019_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","article-title":"Recurrent optic neuromyelitis with endocrinopathies: a new syndrome","volume":"45","author":"Vernant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib47","first-page":"1","article-title":"Idiopathic intracranial hypertension","volume":"121","author":"Dhungana","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2010.03.019_bib48","first-page":"155","article-title":"Idiopathic intracranial hypertension (Pseudotumor cerebri), a prospective study of 54 patients","volume":"114","author":"Wall","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2010.03.019_bib49","series-title":"Walsh and Hoyt's clinical neuro-ophthalmology: the essentials","author":"Miller","year":"2007"},{"key":"10.1016\/j.ncl.2010.03.019_bib50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.46.5.1226","article-title":"Coexistence of migraine and idiopathic intracranial hypertension without papilledema","volume":"46","author":"Mathew","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ncl.2010.03.019_bib52","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archopht.1985.01050080048018","article-title":"The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy","volume":"103","author":"Guyer","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.nrl.0000159981.73413.2e","article-title":"Neuro-ophthalmic emergencies for the neurologist","volume":"11","author":"Purvin","year":"2005","journal-title":"Neurologist"},{"key":"10.1016\/j.ncl.2010.03.019_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11916-006-0071-6","article-title":"Giant cell arteritis","volume":"10","author":"Schwedt","year":"2006","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.ncl.2010.03.019_bib55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2007-979680","article-title":"Treatment of diplopia","volume":"27","author":"Phillips","year":"2007","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.019_bib56","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ophtha.2004.03.013","article-title":"Strabismus surgery for adults, a report by the American Academy of Ophthalmology","volume":"111","author":"Mills","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.prs.0000263655.47148.9e","article-title":"Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari Technique): experience and progression after more than 3000 operations over 20 years","volume":"120","author":"Richter","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ncl.2010.03.019_bib58","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archopht.1994.01090200069025","article-title":"The natural history and results of treatment of superior oblique myokymia","volume":"112","author":"Brazis","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib59","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3171\/jns.1998.89.6.1020","article-title":"Microvascular decompression for superior oblique myokymia: first experience","volume":"89","author":"Samii","year":"1998","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ncl.2010.03.019_bib60","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00041327-200409000-00012","article-title":"Superior oblique myokymia caused by vascular compression","volume":"24","author":"Hashimoto","year":"2004","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/01658109209058130","article-title":"Neuroophthalmological evaluation of superior oblique myokymia","volume":"12","author":"Komai","year":"1992","journal-title":"Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.40.2.367","article-title":"Superior oblique myokymia associated with a posterior fossa tumor: oculographic correlation with an idiopathic case","volume":"40","author":"Morrow","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib63","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/WNL.41.10.1679","article-title":"Superior oblique myokymia: quantitative description of the eye movement","volume":"41","author":"Thurston","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib64","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archopht.1991.01080120094034","article-title":"Superior oblique myokymia: quantitative characteristics of the eye movements in three patients","volume":"109","author":"Leigh","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib65","first-page":"59","volume":"42","author":"Inagaki","year":"1983","journal-title":"Folia Ophthalmol Jpn"},{"key":"10.1016\/j.ncl.2010.03.019_bib66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3757\/jser.42.59","volume":"42","author":"Ishikawa","year":"1983","journal-title":"Equilib Res"},{"key":"10.1016\/j.ncl.2010.03.019_bib67","first-page":"254","article-title":"Superior +oblique myokymia: efficacy of medical treatment","volume":"11","author":"William","year":"2007","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ncl.2010.03.019_bib68","first-page":"87","article-title":"Resolution of superior oblique myokymia with memantine","volume":"12","author":"Jain","year":"2008","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ncl.2010.03.019_bib69","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9394(02)01343-0","article-title":"Gabapentin attenuates superior oblique myokymia","volume":"133","author":"Tomask","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00041327-200403000-00032","article-title":"Superior oblique myokymia improved with Gabapentin","volume":"24","author":"Deokule","year":"2004","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajo.2009.05.010","article-title":"Superior oblique myectomy and trochlear resection for superior oblique myokymia","volume":"148","author":"Ruttum","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3928\/0191-3913-19840501-04","article-title":"Superior oblique myokymia: preliminary results of surgical treatment","volume":"21","author":"Palmer","year":"1984","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.ncl.2010.03.019_bib73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.10118","article-title":"Superior oblique myokymia: magnetic resonance imaging support for the neurovascular compression hypothesis","volume":"51","author":"Yousry","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib74","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00701-005-0582-7","article-title":"Resolution of superior oblique myokymia following microvascular decompression of trochlear nerve","volume":"147","author":"Mikami","year":"2005","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.ncl.2010.03.019_bib75","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archneur.1983.04210070066021","article-title":"Superior oblique myokymia","volume":"40","author":"Bringewald","year":"1983","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib76","first-page":"472","article-title":"Results of extraocular muscle surgery for superior oblique myokymia","volume":"13","author":"Agarwal","year":"2009","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.ncl.2010.03.019_bib77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00055735-200110000-00010","article-title":"Nystagmus","volume":"12","author":"Gottlob","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib78","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo.77.4.228","article-title":"Ocular and vision defects in preschool children","volume":"77","author":"Stayte","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib79","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/bjo.2005.070045","article-title":"Social and visual function in nystagmus","volume":"89","author":"Piling","year":"2005","journal-title":"Br J\u00a0Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib80","first-page":"604","article-title":"Congenital nystagmus: hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model","volume":"4","author":"Jacobs","year":"2004","journal-title":"J\u00a0Vis"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.019_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.21065","article-title":"Congenital nystagmus: randomized. controlled, double-masked trial of memantine\/gabapentin","volume":"61","author":"Mclean","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib82","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjo.2005.086322","article-title":"The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study","volume":"90","author":"Shery","year":"2006","journal-title":"Br J\u00a0Ophthalmol"},{"issue":"7","key":"10.1016\/j.ncl.2010.03.019_bib83","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","article-title":"The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus","volume":"54","author":"Dieterich","year":"1991","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"8","key":"10.1016\/j.ncl.2010.03.019_bib84","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/00005537-200108000-00029","article-title":"Role of clonazepam in the treatment of idiopathic downbeat nystagmus","volume":"111","author":"Young","year":"2001","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.019_bib85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1212\/01.WNL.0000136226.52639.35","article-title":"Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus","volume":"63","author":"Helmchen","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib86","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ophtha.2008.12.031","article-title":"FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm","volume":"116","author":"Blackburn","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib87","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1749-6632.2002.tb02861.x","article-title":"Botulinum toxin therapy for apraxia of lid opening","volume":"956","author":"Boghen","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.ncl.2010.03.019_bib88","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/IAE.0b013e318074bc39","article-title":"Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion","volume":"27","author":"Murakami","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ncl.2010.03.019_bib89","first-page":"599","article-title":"Streptokinase in the treatment of central retinal vein occlusion: a controlled trial","volume":"94","author":"Kohner","year":"1974","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.ncl.2010.03.019_bib90","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/bmj.1.6009.550","article-title":"Streptokinase in central retinal vein occlusion: a controlled clinical trial","volume":"1","author":"Kohner","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.ncl.2010.03.019_bib91","first-page":"471","article-title":"Thrombolytic therapy for central retinal vein occlusion: results of a pilot study","volume":"94","author":"Elman","year":"1996","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ncl.2010.03.019_bib92","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00920049","article-title":"Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion\u2014a 10-year prospective study","volume":"228","author":"Hayreh","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archopht.1986.01050130044017","article-title":"Argon laser scatter photocoagulation for prevention of neovascularization and hemorrhage in branch vein occlusion. Branch Vein Occlusion Study Group","volume":"104","year":"1986","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ncl.2010.03.019_bib95","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/IAE.0b013e3181744153","article-title":"Radial optic neurotomy for central retinal vein occlusion: results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"28","author":"Arevalo","year":"2008","journal-title":"Retina"},{"issue":"13","key":"10.1016\/j.ncl.2010.03.019_bib96","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a-therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ncl.2010.03.019_bib97","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM198708133170703","article-title":"A\u00a0pilot trial of Cop 1 in exacerbating remitting multiple sclerosis","volume":"317","author":"Bornstein","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.019_bib98","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","article-title":"Plasma exchange for severe optic neuritis: treatment of 10 patients","volume":"63","author":"Ruprecht","year":"2004","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2010.03.019_bib99","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"For the international Pediatric MS Group","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0161-6420(98)93028-7","article-title":"Bartonella henselae neuroretinitis in cat scratch disease. Diagnosis, management, and sequelae","volume":"105","author":"Reed","year":"1998","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.019_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.WNO.0000166060.35366.70","article-title":"Reactive Lyme serology in optic neuritis","volume":"25","author":"Sibony","year":"2005","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib102","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2010.03.019_bib103","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2010.03.019_bib104","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-2007-1019130","article-title":"Acute disseminated encephalomyelitis: current understanding and controversies","volume":"28","author":"Young","year":"2008","journal-title":"Semin Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2010.03.019_bib105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab retrospective analysis of 25 patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2010.03.019_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","article-title":"Fulminant idiopathic intracranial hypertension","volume":"68","author":"Thambisetty","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00127893-200107010-00002","article-title":"Idiopathic intracranial hypertension (Pseudotumor cerebri): a reappraisal","volume":"7","author":"Digre","year":"2001","journal-title":"Neurologist"},{"key":"10.1016\/j.ncl.2010.03.019_bib108","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICU.0b013e3283112d3e","article-title":"Idiopathic intracranial hypertension(Pseudotumor cerebri)","volume":"19","author":"Randhawa","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib109","unstructured":"Gans MS. Idiopathic intracranial hypertension treatment and medication. Medscape and Medline continually updated clinical reference articles. Updated Auguust 18, 2009. Available at: www.emedicine.com. Accessed March 29, 2010."},{"issue":"1","key":"10.1016\/j.ncl.2010.03.019_bib110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)72847-8","article-title":"High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri","volume":"118","author":"Liu","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.019_bib111","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2006.12.040","article-title":"Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (Pseudotumor cerebri)","volume":"143","author":"Daniels","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib112","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archinte.133.5.802","article-title":"Pseudotumor cerebri created by rice reduction diet","volume":"133","author":"Newborg","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ncl.2010.03.019_bib113","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.45.9.1655","article-title":"Effects of weight loss on the course of idiopathic intracranial hypertension in women","volume":"45","author":"Kupersmith","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib114","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0161-6420(98)91234-9","article-title":"The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (Pseudotumor cerebri)","volume":"105","author":"Johnson","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ncl.2010.03.019_bib115","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1468-2982.2008.01778.x","article-title":"Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension)","volume":"28","author":"Brazis","year":"2008","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib116","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/FOC-07\/11\/E7","article-title":"Optic nerve sheath fenestration for vision preservation in idiopathic intracranial hypertension","volume":"23","author":"Agarwal","year":"2007","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ncl.2010.03.019_bib117","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1442-9071.2006.01301.x","article-title":"Visual outcomes for optic nerve sheath fenestration in pseudotumor cerebri and related conditions","volume":"34","author":"Chandrasekaran","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib118","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/FOC-07\/11\/E6","article-title":"Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension","volume":"23","author":"Feldon","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib119","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2009.9.FOCUS09165","article-title":"Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension","volume":"27","author":"Arac","year":"2009","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ncl.2010.03.019_bib120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ncl.2010.03.019_bib121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WNO.0b013e31814b273d","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab","volume":"27","author":"Bennett","year":"2007","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib122","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.iio.0000167238.26526.a8","article-title":"Benign essential blepharospasm","volume":"45","author":"Ben Simon","year":"2005","journal-title":"Int Ophthalmol Clin"},{"issue":"19","key":"10.1016\/j.ncl.2010.03.019_bib123","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Subcommittee of the American Academy of Neurology. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib124","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.870110107","article-title":"Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study","volume":"11","author":"Girlanda","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2010.03.019_bib125","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","article-title":"Botulinum A toxin for cranial cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic","year":"1987","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.019_bib126","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000115731","article-title":"Meige's syndrome: acute and chronic responses to clonazepan and anticholinergics","volume":"23","author":"H\u00edpola","year":"1984","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2010.03.019_bib127","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and orofacial-cervical dystonia: clinical and pharmacologic findings in 100 patients","volume":"13","author":"Jankovic","year":"1983","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2010.03.019_bib128","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/mds.20635","article-title":"Relationship between eye symptoms and blepharospasm: a multicenter case-control study","volume":"20","author":"Martino","year":"2005","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.IOP.0000162429.97307.4D","article-title":"Assessment of blepharospasm surgery using an improved disability scale: study of 138 patients","volume":"21","author":"Grivet","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ncl.2010.03.019_bib130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0161-6420(98)93484-4","article-title":"Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm","volume":"105","author":"Wirtschafter","year":"1998","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ncl.2010.03.019_bib131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02844310050159873","article-title":"Superselective neurectomy with periorbital primary reconstruction for blepharospasm. Case report","volume":"34","author":"Nemoto","year":"2000","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"10.1016\/j.ncl.2010.03.019_bib132","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.58.12.1843","article-title":"Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening","volume":"58","author":"Forget","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2010.03.019_bib133","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajo.2007.10.017","article-title":"Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening","volume":"145","author":"Georgescu","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ncl.2010.03.019_bib134","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1212\/01.WNL.0000113751.19247.84","article-title":"The effects of levodopa on apraxia of lid opening: a case report","volume":"62","author":"Yamada","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2010.03.019_bib135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00055735-199612000-00008","article-title":"Disorders of facial motor function","volume":"7","author":"Boghen","year":"1996","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861910000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T08:58:13Z","timestamp":1636361893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861910000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0733861910000575"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2010.03.019","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}